Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort

• Published in: BMC cancer 2017-01, Vol.17 (1), p.84-84, Article 84
• Main Authors: Vierkant, Robert A, Degnim, Amy C, Radisky, Derek C, Visscher, Daniel W, Heinzen, Ethan P, Frank, Ryan D, Winham, Stacey J, Frost, Marlene H, Scott, Christopher G, Jensen, Matthew R, Ghosh, Karthik, Manduca, Armando, Brandt, Kathleen R, Whaley, Dana H, Hartmann, Lynn C, Vachon, Celine M
• Format: Article
• Language: English
• Subjects: Biopsy - methods; Breast - pathology; Breast biopsy; Breast cancer; Breast Density - physiology; Breast Neoplasms - pathology; Cohort Studies; Complications and side effects; Diagnosis; Female; Humans; Hyperplasia; Hyperplasia - pathology; Mammography; Mammography - methods; Medical records; Middle Aged; Precancerous Conditions - pathology; Risk Assessment; Risk Factors; Studies; Womens health
• ISSN: 1471-2407; 1471-2407
• DOI: 10.1186/s12885-017-3082-2

Atypical hyperplasia (AH) and mammographic breast density (MBD) are established risk factors for breast cancer (BC), but their joint contributions are not well understood. We examine associations of MBD and BC by histologic impression, including AH, in a subcohort of women from the Mayo Clinic Benign Breast Disease Cohort. Women with a diagnosis of BBD and mammogram between 1985 and 2001 were eligible. Histologic impression was assessed via pathology review and coded as non-proliferative disease (NP), proliferative disease without atypia (PDWA) and AH. MBD was assessed clinically using parenchymal pattern (PP) or BI-RADS criteria and categorized as low, moderate or high. Percent density (PD) was also available for a subset of women. BC and clinical information were obtained by questionnaires, medical records and the Mayo Clinic Tumor Registry. Women were followed from date of benign biopsy to BC, death or last contact. Standardized incidence ratios (SIRs) compared the observed number of BCs to expected counts. Cox regression estimated multivariate-adjusted MBD hazard ratios. Of the 6271 women included in the study, 1132 (18.0%) had low MBD, 2921 (46.6%) had moderate MBD, and 2218 (35.4%) had high MBD. A total of 3532 women (56.3%) had NP, 2269 (36.2%) had PDWA and 470 (7.5%) had AH. Over a median follow-up of 14.3 years, 528 BCs were observed. The association of MBD and BC risk differed by histologic impression (p-interaction = 0.03), such that there was a strong MBD and BC association among NP (p 50%) demonstrated marginal evidence of increased BC risk (SIR 4.98), but results were not statistically significant. We found no evidence of an association between MBD and subsequent BC risk in women with AH.